Cargando…

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world

BACKGROUND: Mutations in STK11 (STK11m) and frequently co-occurring KRAS mutations (KRASm/STK11m) are associated with poor survival in metastatic NSCLC (mNSCLC) immuno-oncology trials. There are limited data regarding the prognostic significance of these mutations in a real-world setting. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shire, Norah J., Klein, Alyssa B., Golozar, Asieh, Collins, Jenna M., Fraeman, Kathy H., Nordstrom, Beth L., McEwen, Robert, Hembrough, Todd, Rizvi, Naiyer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470384/ https://www.ncbi.nlm.nih.gov/pubmed/32881920 http://dx.doi.org/10.1371/journal.pone.0238358

Ejemplares similares

Tumor loss-of-function mutations in STK11/LKB1 induce cachexia
por: Iyengar, Puneeth, et al.
Publicado: (2023)

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
por: Mograbi, Baharia, et al.
Publicado: (2021)

Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
por: Sumbly, Vikram, et al.
Publicado: (2022)

Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome
por: Lim, W, et al.
Publicado: (2003)

AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1(+) CD8 T cells
por: Li, Huiyu, et al.
Publicado: (2022)

STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation
por: Granado-Martínez, Paula, et al.
Publicado: (2020)

STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
por: Pons-Tostivint, Elvire, et al.
Publicado: (2021)

LKB1/STK11 Tumor Suppressor Reduces Angiogenesis by Directly Interacting with VEGFR2 in Tumorigenesis
por: Rho, Seung Bae, et al.
Publicado: (2023)

Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome
por: Hearle, Nicholas CM, et al.
Publicado: (2005)

Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9
por: Berthelsen, Martin F., et al.
Publicado: (2021)

Must Peutz-Jeghers syndrome patients have the LKB1/STK11 gene mutation? A case report and review of the literature
por: Duan, Fu-Xiao, et al.
Publicado: (2018)

LKB1: Can We Target an Hidden Target? Focus on NSCLC
por: Ndembe, Gloriana, et al.
Publicado: (2022)

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
por: Fraeman, Kathy H., et al.
Publicado: (2013)

Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter
por: Nordstrom, Beth L., et al.
Publicado: (2008)

Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
por: An, Josiah, et al.
Publicado: (2021)

XPO1-mutant NSCLC without STK11/KEAP1 mutations may predict better survival to immunotherapy
por: Li, Xuanzong, et al.
Publicado: (2021)

The negative relationship between patients with NSCLC harbored STK11/KEAP1 copy number variation and immune microenvironment infiltration
por: Zhang, Chenyue
Publicado: (2021)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
por: Fricke, Jeremy, et al.
Publicado: (2020)

Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
por: Cheng, Fang-Ju, et al.
Publicado: (2020)

Peutz-Jeghers syndrome with germline mutation of STK11
por: Chae, Hyun-Dong, et al.
Publicado: (2014)

Transcription factor-7–like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, β cell growth, and insulin secretion
por: Nguyen-Tu, Marie-Sophie, et al.
Publicado: (2018)

Special issues in data management
por: Xiao, Norah, et al.
Publicado: (2012)

Mutations in STK11 gene in Czech Peutz-Jeghers patients
por: Vasovčák, Peter, et al.
Publicado: (2009)

Mutational Analysis of STK11 h Gene in Ovarian Carcinomas
por: Nishioka, Yoshihiro, et al.
Publicado: (1999)

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
por: Aerts, Hugo J. W. L., et al.
Publicado: (2016)

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases
por: Landis, Sarah H., et al.
Publicado: (2013)

Validation of Claims Algorithms for Progression to Metastatic Cancer in Patients with Breast, Non-small Cell Lung, and Colorectal Cancer
por: Nordstrom, Beth L., et al.
Publicado: (2016)

STK system acceptance tests
por: Grau, X F
Publicado: (1997)

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene
por: Masuda, Kenta, et al.
Publicado: (2016)

Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
por: Aerts, Hugo J. W. L., et al.
Publicado: (2017)

Identification of functional genetic variation in exome sequence analysis
por: Jaffe, Andrew, et al.
Publicado: (2011)

Complete STK11 Deletion and Atypical Symptoms in Peutz-Jeghers Syndrome
por: Jang, Myeong Sun, et al.
Publicado: (2017)

STK11 is required for the normal program of ciliated cell differentiation in airways
por: Chu, Qiqi, et al.
Publicado: (2019)

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
por: Meraz, Ismail M., et al.
Publicado: (2022)

LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014)

Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network
por: Shantakumar, Sumitra, et al.
Publicado: (2016)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner
por: Meng, Jieru, et al.
Publicado: (2013)

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells
por: Della Corte, Carminia Maria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ufbvpt2kavecb3iicclj7054bb